Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarwyn Val. Regulatory News (MVI)

Share Price Information for Marwyn Val. (MVI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 90.50
Bid: 90.00
Ask: 91.00
Change: 0.00 (0.00%)
Spread: 1.00 (1.111%)
Open: 90.50
High: 90.50
Low: 90.50
Prev. Close: 90.50
MVI Live PriceLast checked at -
Marwyn Value Investors is an Investment Trust

To achieve long-term capital appreciation through its investment in the Master Fund primarily by focusing in mid cap businesses headquartered in the UK, Europe or North America.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of AGM

23 Oct 2020 07:00

RNS Number : 9788C
Marwyn Value Investors Limited
23 October 2020
 

LEI: 213800L5751QTTVEA774

23 October 2020

MARWYN VALUE INVESTORS LIMITED (THE "COMPANY")

NOTICE OF ANNUAL GENERAL MEETING

The Company announces that the Notice of the Annual General Meeting of the Company is being posted to shareholders today. The Annual General Meeting is to be held at the offices of Axio Capital Solutions Limited, One Waverley Place, Union Street, St Helier, Jersey, JE1 1AX at 10 a.m. on 17 November 2020.

The Notice will also be available on the Company's website at www.marwynvalue.com/company-information/documents.

OPERATIONAL UPDATES

The Company also announces that following changes to the board of directors and corporate governance improvements announced in July, the Company has conducted a review of its operating structure with the intention of improving operating efficiencies for the Company, Marwyn Value Investors LP ("MVI LP") and Marwyn Value Investors II LP ("MVI II LP") (the Company, MVI LP and MVI II LP together, the "Fund"). Following discussions with each of the relevant parties and with the unanimous approval of the Company's board of directors, a number of changes are being made in the Fund's operations:

1) The administration services provided to the Company by Axio Capital Solutions Limited, in addition to those provided by Mitsubishi UFJ Alternative Fund Services (Ireland Limited) to MVI LP, and Apex Fund and Corporate Services (Jersey) Limited to MVI II will be unified under a single provider: Aztec Financial Services (Jersey) Limited ("Aztec")1. Established in 2001, the Aztec Group is an award-winning independent provider of fund and corporate services, employing more than 950 people across Jersey, Guernsey, Luxembourg, the Netherlands and the UK. Owner-managed, the Group administers over 440 funds and 4,500 entities for a range of clients, including private equity, real asset and debt fund managers, institutional investors and multi-national corporations. Aztec also have an experienced team which specialise in the establishment and administration of listed fund vehicles for alternative investment managers.

2) Subject to shareholder approval at the Annual General Meeting, the audit services provided to the Company and MVI LP by PricewaterhouseCoopers LLP, in addition to those provided by Ernst & Young LLP to MVI II will be unified in a single provider: Baker Tilly Channel Islands Limited1. This is included as Resolution 4 in the Notice of Annual General Meeting. Baker Tilly Channel Islands is the Channel Islands member firm of Baker Tilly International, a top 10 Global Accountancy Network with member firms in more than 146 territories and combined revenues of US$3.9bn.

3) In order to appropriately segregate the activities of the Company, new Fund Financial Director ("FD") and Corporate Director ("CD") roles are being created, to act as dedicated resources for the board of directors and provide effective oversight of service providers to the Company. The FD and CD roles will be undertaken by individuals with significant knowledge of the Company, its structure and operations.

Commenting on the improvements, Robert Ware, the Company's Chairman, noted, "We are pleased to report further progress around the Fund's corporate governance arrangements and simplification of the Fund's operations. We would like to extend our thanks to the departing administrator and auditor for their efforts and look forward to working alongside Aztec and Baker Tilly going forwards."

1The appointment of both Aztec and Baker Tilly is subject to consent from the Jersey Financial Services Commission for their appointment as service providers to MVI II which is regulated by the Jersey Financial Services Commission as a Jersey Expert Fund.

Company enquiries:

Louisa Bonney / Scott Danks

Telephone: 01534 761240

 

Gillian Martin / Richard Bootle / Owen Matthews

Liberum Capital Limited

Telephone: 020 3100 2200

 

PR enquiries:

Alex Child-Villiers / Will Barker

Temple Bar Advisory Limited

Telephone: 07795 425580 / 07827 960151

 

A copy of this announcement will be available on the Company's website at www.marwynvalue.com/company-information/rns. Neither the content of the Company's website, nor the content on any website accessible from hyperlinks on its website for any other website, is incorporated into, or forms part of, this announcement nor, unless previously published by means of a recognised information service, should any such content be relied upon in reaching a decision as to whether or not to acquire, continue to hold, or dispose of, securities in the Company.

This announcement may include "forward-looking statements". All statements other than statements of historical facts included in this announcement, including, without limitation, those regarding the Company's financial position, business strategy, plans and objectives of management for future operations (including development plans and objectives relating to the Company's products and services) are forward-looking statements. Forward-looking statements are subject to risks and uncertainties and accordingly the Company's actual future financial results and operational performance may differ materially from the results and performance expressed in, or implied by, the statements. These factors include but are not limited to those described in the formal Prospectus. These forward-looking statements speak only as at the date of this announcement. The Company expressly disclaims any obligation or undertaking to update or revise any forward-looking statements contained herein to reflect actual results or any change in the assumptions, conditions or circumstances on which any such statements are based unless required to do so by the Financial Services and Markets Act 2000, or other applicable laws, regulations or rules.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOAFESFWEESSEES
Date   Source Headline
22nd Apr 202411:00 amRNSNet Asset Values
15th Apr 202411:00 amRNSNet Asset Values
9th Apr 202410:10 amRNSNet Asset Value - 2021 Realisation Shares
9th Apr 202410:05 amRNSNet Asset Value - 2016 Realisation Shares
9th Apr 202410:00 amRNSNet Asset Value - Ordinary Shares
28th Mar 20243:26 pmRNSShare Transfer
21st Mar 20243:53 pmRNSNotification of Major Interests in Shares
21st Mar 20243:51 pmRNSNotification of Major Interests in Shares
20th Mar 20241:42 pmRNSShare Transfer
18th Mar 202411:00 amRNSNet Asset Values
11th Mar 202411:00 amRNSNet Asset Values
7th Mar 20241:52 pmRNSNotification of Major Interests in Shares
4th Mar 202410:10 amRNSNet Asset Value - 2021 Realisation Shares
4th Mar 202410:05 amRNSNet Asset Value - 2016 Realisation Shares
4th Mar 202410:00 amRNSNet Asset Value - Ordinary Shares
28th Feb 202410:10 amRNSNet Asset Value - 2021 Realisation Shares
28th Feb 202410:05 amRNSNet Asset Value - 2016 Realisation Shares
28th Feb 202410:00 amRNSNet Asset Value - Ordinary Shares
23rd Feb 202410:10 amRNSNet Asset Value - 2021 Realisation Shares
23rd Feb 202410:05 amRNSNet Asset Value - 2016 Realisation Shares
23rd Feb 202410:00 amRNSNet Asset Value - Ordinary Shares
14th Feb 202410:10 amRNSNet Asset Value - 2021 Realisation Shares
14th Feb 202410:05 amRNSNet Asset Value - 2016 Realisation Shares
14th Feb 202410:00 amRNSNet Asset Value - Ordinary Shares
2nd Feb 202410:10 amRNSNet Asset Value - 2021 Realisation Shares
2nd Feb 202410:05 amRNSNet Asset Value - 2016 Realisation Shares
2nd Feb 202410:00 amRNSNet Asset Value - Ordinary Shares
26th Jan 202410:10 amRNSNet Asset Value - 2021 Realisation Shares
26th Jan 202410:05 amRNSNet Asset Value - 2016 Realisation Shares
26th Jan 202410:00 amRNSNet Asset Value - Ordinary Shares
25th Jan 20247:00 amRNSInterim Dividend to Ordinary Shareholders
15th Jan 202410:10 amRNSNet Asset Value - 2021 Realisation Shares
15th Jan 202410:05 amRNSNet Asset Value - 2016 Realisation Shares
15th Jan 202410:00 amRNSNet Asset Value - Ordinary Shares
29th Dec 202310:10 amRNSNet Asset Value - 2021 Realisation Shares
29th Dec 202310:05 amRNSNet Asset Value - 2016 Realisation Shares
29th Dec 202310:00 amRNSNet Asset Value - Ordinary Shares
22nd Dec 202310:10 amRNSNet Asset Value - 2021 Realisation Shares
22nd Dec 202310:05 amRNSNet Asset Value - 2016 Realisation Shares
22nd Dec 202310:00 amRNSNet Asset Value - Ordinary Shares
18th Dec 20235:53 pmRNSShare Dealings
15th Dec 202311:42 amRNSNotification of Major Interests in Shares
14th Dec 20231:02 pmRNSResult of AGM
14th Dec 202310:10 amRNSNet Asset Value - 2021 Realisation Shares
14th Dec 202310:05 amRNSNet Asset Value - 2016 Realisation Shares
14th Dec 202310:00 amRNSNet Asset Value - Ordinary Shares
12th Dec 202311:50 amRNSNotification of major interests in shares
11th Dec 20234:35 pmRNSShare Transfer
1st Dec 20231:21 pmRNSNotification of major interests in shares
1st Dec 202310:10 amRNSNet Asset Value - 2021 Realisation Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.